Insider · CIK 0001413006
Eldridge George A
Reports to the SEC for 1 company · BOSTON,, MA
Transactions
50
Companies
1
Filings
5
CIK
0001413006
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-06-14 | JBIOJade Biosciences, Inc.M Exercise/Conversion | +$32.1K |
| 2024-06-14 | JBIOJade Biosciences, Inc.S Sale | −$375K |
| 2024-06-14 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-04-10 | JBIOJade Biosciences, Inc.M Exercise/Conversion | +$16.1K |
| 2024-04-10 | JBIOJade Biosciences, Inc.S Sale | −$180K |
| 2024-04-10 | JBIOJade Biosciences, Inc.S Sale | −$21.3K |
| 2024-04-10 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-04-01 | JBIOJade Biosciences, Inc.M Exercise/Conversion | +$26.7K |
| 2024-04-01 | JBIOJade Biosciences, Inc.S Sale | −$390K |
| 2024-04-01 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-03-13 | JBIOJade Biosciences, Inc.M Exercise/Conversion | +$4,314.24 |
| 2024-03-13 | JBIOJade Biosciences, Inc.S Sale | −$50.4K |
| 2024-03-13 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-03-12 | JBIOJade Biosciences, Inc.M Exercise/Conversion | +$4,389.14 |
| 2024-03-12 | JBIOJade Biosciences, Inc.S Sale | −$51.4K |
| 2024-03-12 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-03-11 | JBIOJade Biosciences, Inc.M Exercise/Conversion | +$7,346.62 |
| 2024-03-11 | JBIOJade Biosciences, Inc.S Sale | −$86.4K |
| 2024-03-11 | JBIOJade Biosciences, Inc.S Sale | −$263.05 |
| 2024-03-11 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-03-08 | JBIOJade Biosciences, Inc.M Exercise/Conversion | +$243.96 |
| 2024-03-08 | JBIOJade Biosciences, Inc.S Sale | −$2,850 |
| 2024-03-08 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-03-07 | JBIOJade Biosciences, Inc.M Exercise/Conversion | +$47.9K |
| 2024-03-07 | JBIOJade Biosciences, Inc.S Sale | −$560K |
| 2024-03-07 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-03-07 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-01-22 | JBIOJade Biosciences, Inc. · Stock Options (Right to Buy)A Award | — |
| 2023-02-07 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-12-12 | JBIOJade Biosciences, Inc.M Exercise/Conversion | +$21.4K |
| 2022-12-12 | JBIOJade Biosciences, Inc.S Sale | −$300K |
| 2022-12-12 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-12-12 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-12-09 | JBIOJade Biosciences, Inc.S Sale | −$14.7K |
| 2022-12-09 | JBIOJade Biosciences, Inc.M Exercise/Conversion | +$8,493.66 |
| 2022-12-09 | JBIOJade Biosciences, Inc.S Sale | −$82.1K |
| 2022-12-09 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-12-08 | JBIOJade Biosciences, Inc.M Exercise/Conversion | +$25.7K |
| 2022-12-08 | JBIOJade Biosciences, Inc.S Sale | −$19.3K |
| 2022-12-08 | JBIOJade Biosciences, Inc.S Sale | −$411.6 |
| 2022-12-08 | JBIOJade Biosciences, Inc.S Sale | −$267K |
| 2022-12-08 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-12-08 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-12-07 | JBIOJade Biosciences, Inc.M Exercise/Conversion | +$24.9K |
| 2022-12-07 | JBIOJade Biosciences, Inc.S Sale | −$137K |
| 2022-12-07 | JBIOJade Biosciences, Inc.S Sale | −$93K |
| 2022-12-07 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-11-30 | JBIOJade Biosciences, Inc.M Exercise/Conversion | +$181.9 |
| 2022-11-30 | JBIOJade Biosciences, Inc.S Sale | −$1,620.134 |
| 2022-11-30 | JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
Recent filings
- 4Eldridge George A0001415889-24-016995SEC(opens sec.gov)
- 4Eldridge George A0001415889-24-010773SEC(opens sec.gov)
- 4Eldridge George A0001415889-24-010136SEC(opens sec.gov)
- 4Eldridge George A0001415889-24-008033SEC(opens sec.gov)
- 4Eldridge George A0001415889-24-007534SEC(opens sec.gov)
Companies
Address
C/O AEROVATE THERAPEUTICS, INC. 200 BERKELEY STREET, FLOOR 18
BOSTON,, MA, 02116